CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

The Potential for AI in Life Sciences

Life Sciences Review | Wednesday, March 25, 2020
Tweet

Life sciences organizations can leverage AI in several ways to drive insightful decisions on all aspects of their business.


FREMONT, CA: The pharma and life sciences industry is faced with mounting regulatory oversight, decreasing R&D productivity, and hurdles to growth and profitability. The regulations are forcing the pharma and life sciences industry to change its status quo. As a result, the life sciences industry is compelled to focus on relatively nascent and evolving technologies like Artificial Intelligence (AI). Infusion of AI in the life sciences industry allows firms to rationalize internal costs and focus on better profiling and targeting clients and medical practitioners. Here are some AI opportunities in the life sciences industry.


• Supporting Innovation for New Products


The biggest goal of the life sciences industry is to advance research and innovation for new drugs. AI has opened up new ways to help in the innovation of new products. The most widely used method in the industry is to develop sophisticated algorithms that can identify and analyze the patterns and causes of diseases. The data mined by the AI system can be used to predict the reactions of the body in response to the drug. 


This can be used to make any necessary changes in the existing medicine to offer better results.


• Improving Diagnostics


AI's first application was in improving diagnostic techniques. Diagnosis is the most fundamental step in the treatment. If the diagnosis is wrong, then the whole treatment will be wrong, which can be fatal for the patients. AI-based automated diagnosis is faster and better as compared to traditional diagnosis methods. AI systems can employ microscopic magnifications to find disease patterns and cross-reference the gathered data with the patient's medical history.


• Optimizing Safety Information


The expiry dates and safety periods for medicine are generally decided considering the chemical components, but these analyses are not always very efficient and accurate. The software can effectively analyze the pieces of medicines keeping in mind the several constraints not limited to the chemical factors but also other usage and environmental factors. The machine learning systems can be leveraged to record past medicines usage patterns to decide the future usage patterns of the medicine.


See also: Top Artificial Intelligence Solution Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-potential-for-ai-in-life-sciences--nwid-121.html